Rockwell Medical logo

Rockwell Medical share price today

(RMTI)

Rockwell Medical share price is $2.26 & ₹193.93 as on 7 Jan 2025, 2.30 'hrs' IST

$2.26

▲

-0.08

(-3.22%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Rockwell Medical share price in Dollar and Rupees. Guide to invest in Rockwell Medical stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rockwell Medical, along with analyst recommendations, forecasts, and comprehensive financials.

Rockwell Medical share price movements

  • Today's Low: $2.25
    Today's High: $2.41

    Day's Volatility :6.85%

  • 52 Weeks Low: $1.16
    52 Weeks High: $5.15

    52 Weeks Volatility :77.48%

Rockwell Medical Returns

PeriodRockwell Medical IncIndex (Russel 2000)
3 Months
-31.37%
0.0%
6 Months
27.32%
0.0%
1 Year
41.21%
0.0%
3 Years
-46.12%
-19.8%

Rockwell Medical Key Statistics

in dollars & INR

Previous Close
$2.33
Open
$2.37
Today's High
$2.41
Today's Low
$2.245
Market Capitalization
$65.9M
Today's Volume
$400.2K
52 Week High
$5.15
52 Week Low
$1.16
Revenue TTM
$94.4M
EBITDA
$-885.0K
Earnings Per Share (EPS)
$-0.04
Profit Margin
-5.06%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-28.9%

How to invest in Rockwell Medical from India?

It is very easy for Indian residents to invest directly in Rockwell Medical from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rockwell Medical stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rockwell Medical or RMTI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rockwell Medical or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rockwell Medical shares which would translate to 0.380 fractional shares of Rockwell Medical as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rockwell Medical, in just a few clicks!

Returns in Rockwell Medical for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Rockwell Medical investment value today

Current value as on today

₹1,40,192

Returns

₹40,192

(+40.19%)

Returns from Rockwell Medical Stock

₹36,970 (+36.97%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Rockwell Medical

-43%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Rockwell Medical on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -43% less investors are searching Rockwell Medical in the last 30 days versus the previous period.

Global Institutional Holdings in Rockwell Medical

  • Armistice Capital, LLC

    11.08%

  • Vanguard Group Inc

    3.73%

  • GlobeFlex Capital, L.P.

    2.30%

  • Marshall Wace Asset Management Ltd

    1.57%

  • Perkins Capital Management Inc

    1.08%

  • Geode Capital Management, LLC

    0.95%

Analyst Recommendation on Rockwell Medical

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Rockwell Medical(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Rockwell Medical

What analysts predicted

Upside of 187.61%

Current:

$2.26

Target:

$6.50

Insights on Rockwell Medical

  • Price Movement

    In the last 7 days, RMTI stock has moved up by 13.7%

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 22.09M → 28.31M (in $), with an average increase of 7.9% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -1.73M → 1.66M (in $), with an average increase of 342.0% per quarter

Rockwell Medical Financials in INR & Dollars

FY18Y/Y Change
Revenue
$63.4M
↑ 10.63%
Net Income
$-32.1M
↑ 23.94%
Net Profit Margin
-50.68%
↓ 5.44%
FY19Y/Y Change
Revenue
$61.3M
↓ 3.29%
Net Income
$-31.1M
↓ 3.26%
Net Profit Margin
-50.7%
↓ 0.02%
FY20Y/Y Change
Revenue
$62.2M
↑ 1.46%
Net Income
$-31.9M
↑ 2.75%
Net Profit Margin
-51.34%
↓ 0.64%
FY21Y/Y Change
Revenue
$61.9M
↓ 0.43%
Net Income
$-35.0M
↑ 9.71%
Net Profit Margin
-56.57%
↓ 5.23%
FY22Y/Y Change
Revenue
$72.8M
↑ 17.57%
Net Income
$-20.6M
↓ 41.26%
Net Profit Margin
-28.26%
↑ 28.31%
FY23Y/Y Change
Revenue
$83.6M
↑ 14.84%
Net Income
$-8.4M
↓ 58.99%
Net Profit Margin
-10.09%
↑ 18.17%
Q2 FY23Q/Q Change
Revenue
$18.1M
↓ 8.07%
Net Income
$-3.3M
↑ 34.35%
Net Profit Margin
-18.28%
↓ 5.77%
Q3 FY23Q/Q Change
Revenue
$23.8M
↑ 31.48%
Net Income
$-1.9M
↓ 43.36%
Net Profit Margin
-7.88%
↑ 10.4%
Q4 FY23Q/Q Change
Revenue
$22.1M
↓ 7.06%
Net Income
$-1.5M
↓ 19.23%
Net Profit Margin
-6.84%
↑ 1.04%
Q1 FY24Q/Q Change
Revenue
$22.7M
↑ 2.64%
Net Income
$-1.7M
↑ 14.48%
Net Profit Margin
-7.63%
↓ 0.79%
Q2 FY24Q/Q Change
Revenue
$25.8M
↑ 13.92%
Net Income
$343.0K
↓ 119.82%
Net Profit Margin
1.33%
↑ 8.96%
Q3 FY24Q/Q Change
Revenue
$28.3M
↑ 9.62%
Net Income
$1.7M
↑ 385.13%
Net Profit Margin
5.88%
↑ 4.55%
FY18Y/Y Change
Profit
$-1.6M
↓ 142.8%
FY19Y/Y Change
Profit
$2.8M
↓ 279.17%
FY20Y/Y Change
Profit
$2.7M
↓ 4.01%
FY21Y/Y Change
Profit
$-2.4M
↓ 188.81%
FY22Y/Y Change
Profit
$4.1M
↓ 268.47%
FY23Y/Y Change
Profit
$8.7M
↑ 113.49%
Q2 FY23Q/Q Change
Profit
$1.0M
↓ 60.25%
Q3 FY23Q/Q Change
Profit
$2.2M
↑ 113.17%
Q4 FY23Q/Q Change
Profit
$2.9M
↑ 30.34%
Q1 FY24Q/Q Change
Profit
$3.1M
↑ 6.76%
Q2 FY24Q/Q Change
Profit
$4.6M
↑ 48.5%
Q3 FY24Q/Q Change
Profit
$6.2M
↑ 37.12%
FY18Y/Y Change
Operating Cash Flow
$-20.4M
↓ 3.29%
Investing Cash Flow
$12.7M
↓ 12.27%
Financing Cash Flow
$22.0M
↓ 1116.97%
FY19Y/Y Change
Operating Cash Flow
$-27.3M
↑ 33.47%
Investing Cash Flow
$-4.7M
↓ 137.33%
Financing Cash Flow
$21.1M
↓ 4.17%
FY20Y/Y Change
Operating Cash Flow
$-29.6M
↑ 8.76%
Investing Cash Flow
$3.2M
↓ 167.62%
Financing Cash Flow
$63.3M
↑ 200.29%
FY21Y/Y Change
Operating Cash Flow
$-33.5M
↑ 13.13%
Investing Cash Flow
$311.0K
↓ 90.32%
Financing Cash Flow
$-2.2M
↓ 103.44%
FY22Y/Y Change
Operating Cash Flow
$-17.4M
↓ 48.07%
Investing Cash Flow
$-2.4M
↓ 870.42%
Financing Cash Flow
$16.6M
↓ 863.29%
Q2 FY23Q/Q Change
Operating Cash Flow
$-1.7M
↓ 55.11%
Investing Cash Flow
$-64.0K
↓ 101.21%
Financing Cash Flow
$-130.0K
↓ 79.4%

Rockwell Medical Technicals Summary

Sell

Neutral

Buy

Rockwell Medical is currently in a neutral trading position according to technical analysis indicators.

Rockwell Medical Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Rockwell Medical Inc
Rockwell Medical Inc
8.88%
27.32%
41.21%
-46.12%
-90.87%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
6.95%
-3.63%
3.11%
80.66%
21.4%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
-1.87%
9.87%
9.24%
27.67%
27.67%
Zoetis Inc.
Zoetis Inc.
-8.33%
-6.27%
-16.74%
-23.18%
20.92%
Viatris Inc.
Viatris Inc.
-4.06%
13.7%
4.87%
-18.19%
-24.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Rockwell Medical Inc
Rockwell Medical Inc
NA
NA
-0.79
0.0
-0.29
-0.04
NA
0.73
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
36.83
36.83
0.33
6.37
0.16
0.12
NA
26.87
Haleon Plc Spon Ads
Haleon Plc Spon Ads
28.91
28.91
1.72
0.34
0.07
0.04
0.02
1.82
Zoetis Inc.
Zoetis Inc.
30.57
30.57
2.53
5.88
0.47
0.15
0.01
11.59
Viatris Inc.
Viatris Inc.
224.4
NA
0.08
2.69
-0.04
0.02
0.04
16.58
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Rockwell Medical Inc
Rockwell Medical Inc
Buy
$65.9M
-90.87%
NA
-5.06%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.0B
21.4%
36.83
17.21%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$43.1B
27.67%
28.91
10.75%
Zoetis Inc.
Zoetis Inc.
Buy
$73.5B
20.92%
30.57
26.55%
Viatris Inc.
Viatris Inc.
Hold
$14.9B
-24.85%
224.4
-5.87%

About Rockwell Medical

rockwell medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (esrd) and chronic kidney disease (ckd) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. rockwell’s new innovative therapy triferic is the only fda approved drug indicated to replace iron and maintain hemoglobin in hemodialysis patients suffering from anemia. via dialysate during each dialysis treatment, triferic replaces the 5-7 mg iron loss that occurs in all patients, maintaining their iron balance. unlike iv iron products, triferic binds iron immediately and completely to transferrin (carrier of iron in the body) upon entering the blood and is then transported directly to the bone marrow to be incorporated into hemoglobin, with no increase in ferritin (stored iron and inflammation) and no anaphylaxis, addressing a significant unmet need in overcoming functional iron deficiency (fid) in esrd patients. visit www
Organization
Rockwell Medical
Employees
237
CEO
Dr. Mark Strobeck Ph.D.
Industry
Health Technology

Management People of Rockwell Medical

NameTitle
Dr. Mark Strobeck Ph.D.
President, CEO & Director
Mr. Jesse Neri
Senior Vice President of Finance
Ms. Megan C. Timmins
Executive VP, Chief Legal Officer & Secretary
Mr. Timothy T. Chole
Senior VP & Chief Commercial Officer
Ms. Heather R. Hunter
Senior VP & Chief Corporate Affairs Officer

Important FAQs about investing in Rockwell Medical from India :

What is Rockwell Medical share price today?

Rockwell Medical share price today stands at $2.26, Open: $2.37 ; Previous Close: $2.33 ; High: $2.41 ; Low: $2.25 ; 52 Week High: $5.15 ; 52 Week Low: $1.16. The stock opens at $2.37, after a previous close of $2.33. The stock reached a daily high of $2.41 and a low of $2.25, with a 52-week high of $5.15 and a 52-week low of $1.16.

Can Indians buy Rockwell Medical shares?

Yes, Indians can invest in the Rockwell Medical (RMTI) from India.

With INDmoney, you can buy Rockwell Medical at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Rockwell Medical at zero transaction cost.

How can I buy Rockwell Medical shares from India?

It is very easy to buy Rockwell Medical from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rockwell Medical be purchased?

Yes, you can buy fractional shares of Rockwell Medical with INDmoney app.

What are the documents required to start investing in Rockwell Medical stocks?

To start investing in Rockwell Medical, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Rockwell Medical

Today’s highest price of Rockwell Medical (RMTI) is $2.41.

Today’s lowest price of Rockwell Medical (RMTI) is $2.25.

What is today's market capitalisation of Rockwell Medical

Today's market capitalisation of Rockwell Medical RMTI is 65.9M

What is the 52 Week High and Low Range of Rockwell Medical

  • 52 Week High

    $5.15

  • 52 Week Low

    $1.16

What are the historical returns of Rockwell Medical?

  • 1 Month Returns

    8.88%

  • 3 Months Returns

    27.32%

  • 1 Year Returns

    41.21%

  • 5 Years Returns

    -90.87%

Who is the Chief Executive Officer (CEO) of Rockwell Medical

Dr. Mark Strobeck Ph.D. is the current Chief Executive Officer (CEO) of Rockwell Medical.